Kimia Biosciences Limited announced the resignation of its Chief Financial Officer (CFO), Mr. Rakesh Chetani, who has stepped down citing personal reasons and a desire to explore new avenues in his professional journey. His resignation was formally submitted on April 22, 2025, and he will be relieved from his duties at the close of business on May 11, 2025.
Transition under SEBI guidelines
The company has confirmed that the resignation was voluntary and not due to any material concerns. As per Regulation 30 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the July 2023 Master Circular, the necessary disclosures have been submitted to the stock exchanges.
Kimia Biosciences also acknowledged the significant contributions of Mr. Chetani during his tenure and thanked him for his service to the company.
What’s next for Kimia Biosciences?
The company has not yet announced a successor for the CFO position. It is expected that a new appointment or interim arrangement will be communicated in due course to ensure smooth financial operations post May 11.
FAQs
Why did Rakesh Chetani resign as CFO of Kimia Biosciences?
He resigned due to personal reasons and to explore other professional opportunities.
When will his resignation be effective?
He will be relieved of his duties after the close of business on May 11, 2025.
Is there a replacement named?
As of now, no successor has been announced.
Were there any material concerns behind his resignation?
No, the resignation was based purely on personal grounds, as confirmed by the company.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
